Mammary tumorigenesis in ApcMin/+ mice is enhanced by X irradiation with a characteristic age dependence

Radiation Research

Volumn 165, Issue 2, 2006, Pages 165-173

  Imaoka, Tatsuhiko ^a,d   Okamoto, Mieko ^b   Nishimura, Mayumi ^a   Nishimura, Yukiko ^a   Ootawara, Masami ^a   Kakinuma, Shizuko ^a   Tokairin, Yutaka ^a,c   Shimada, Yoshiya ^a,d  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NONE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; NUCLEAR PROTEIN;

AGE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST CYST; BREAST TUMOR; CONTROLLED STUDY; FEMALE; GENETIC PREDISPOSITION; MIN MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; NONSENSE MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; RADIATION CARCINOGENESIS; RADIATION DOSE; SIGNAL TRANSDUCTION; SQUAMOUS CELL METAPLASIA; STEM CELL; TUMOR SUPPRESSOR GENE; X RAY; AGING; ANIMAL; C57BL MOUSE; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY;

ANIMALIA;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AGING; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; NEOPLASMS, RADIATION-INDUCED; X-RAYS;

EID: 31444455039     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3502.1     Document Type: Article

References (50)

1. C. M. Ronckers, C. A. Erdmann and C. E. Land, Radiation and breast cancer: A review of current evidence. Breast Cancer Res. 7, 21-32 (2004).
2. A. C. Aisenberg, D. M. Finkelstein, K. P. Doppke, F. C. Koerner, J. F. Boivin and C. G. Willett, High risk of breast carcinoma after irradiation of young women with Hodgkin's disease. Cancer 79, 1203-1210 (1997).
3. S. Bhatia, L. L. Robison, O. Oberlin, M. Greenberg, G. Bunin, F. Fossati-Bellani and A. T. Meadows, Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 334, 745-751 (1996).
4. C. E. Land, J. D. Boice, Jr., R. E. Shore, J. E. Norman and M. Tokunaga, Breast cancer risk from low-dose exposures to ionizing radiation: Results of parallel analysis of three exposed populations of women. J. Natl. Cancer Inst. 65, 353-376 (1980).
5. N. G. Hildreth, R. E. Shore and P. M. Dvoretsky, The risk of breast cancer after irradiation of the thymus in infancy. N. Engl. J. Med. 321, 1281-1284 (1989).
6. B. Modan, A. Chetrit, E. Alfandary and L. Katz, Increased risk of breast cancer after low-dose irradiation. Lancet 1, 629-631 (1989).
7. S. L. Hancock, M. A. Tucker and R. T. Hoppe, Breast cancer after treatment of Hodgkin's disease. J. Natl. Cancer Inst. 85, 25-31 (1993).
8. C. E. Land, M. Tokunaga, K. Koyama, M. Soda, D. L. Preston, I. Nishimori and S. Tokuoka, Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiat. Res. 160, 707-717 (2003).
9. S. A. Benjamin, A. C. Lee, G. M. Angleton, W. J. Saunders, T. J. Keefe and C. H. Mallinckrodt, Mortality in beagles irradiated during prenatal and postnatal development. II. Contribution of benign and malignant neoplasia. Radiat. Res. 150, 330-348 (1998).
10. R. W. Bartstra, P. A. Bentvelzen, J. Zoetelief, A. H. Mulder, J. J. Broerse and D. W. van Bekkum, Induction of mammary tumors in rats by single-dose γ-irradiation at different ages. Radiat. Res. 150, 442-450 (1998).
11. L. K. Su, K. W. Kinzler, B. Vogelstein, A. C. Preisinger, A. R. Moser, C. Luongo, K. A. Gould and W. F. Dove, Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
12. A. R. Shoemaker, A. R. Moser and W. F. Dove, N-ethyl-N-nitrosourea treatment of multiple intestinal neoplasia (Min) mice: Age-related effects on the formation of intestinal adenomas, cystic crypts, and epidermoid cysts. Cancer Res. 55, 4479-4485 (1995).
13. I. L. Steffensen, J. E. Paulsen, T. J. Eide and J. Alexander, 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine increases the numbers of tumors, cystic crypts and aberrant crypt foci in multiple intestinal neoplasia mice. Carcinogenesis 18, 1049-1054 (1997).
14. I. L. Steffensen, H. A. Schut, J. E. Paulsen, A. Andreassen and J. Alexander, Intestinal tumorigenesis in multiple intestinal neoplasia mice induced by the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine: Perinatal susceptibility, regional variation, and correlation with DNA adducts. Cancer Res. 61, 8689-8696 (2001).
15. J. E. Paulsen, I. L. Steffensen, A. Andreassen, R. Vikse and J. Alexander, Neonatal exposure to the food mutagen 2-amino-1-methyl-6- phenylimidazo[4,5-b]pyridine via breast milk or directly induces intestinal tumors in multiple intestinal neoplasia mice. Carcinogenesis 20, 1277-1282 (1999).
16. J. E. Paulsen, I. L. Steffensen, E. Namork, T. J. Eide and J. Alexander, Age-dependent susceptibility to azoxymethane-induced and spontaneous tumorigenesis in the Min/+ mouse. Anticancer Rex. 23. 259-265 (2003).
17. M. Okamoto and H. Yonekawa, Intestinal tumorigenesis in Min mice is enhanced by X-irradiation in an age-dependent manner. J. Radiat. Res. 46, 83-91 (2005).
18. (Min)/+ mice. Carcinogenesis 22, 343-346 (2001).
19. Min mice are not enhanced by Brca2 deficiency. Toxicol. Pathol. 29, 117-125 (2001).
20. (Min)+ mice. Cancer Res. 61, 3480-3485 (2001).
21. A. Rosner, K. Miyoshi, E. Landesman-Bollag, X. Xu, D. C. Seldin, A. R. Moser, C. L. MacLeod, G. Shyamala, A. E. Gillgrass and R. D. Cardiff, Pathway pathology: Histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am. J. Pathol. 161, 1087-1097 (2002).
22. Min, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc. Natl. Acad. Sci. USA 90, 8977-8981 (1993).
23. H307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat. Genet. 20, 62-65 (1998).
24. H307K allele and breast cancer risk. Nat. Genet. 20, 13-14 (1998).
25. K. Furuuchi, M. Tada, H. Yamada, A. Kataoka, N. Furuuchi, J. Hamada, M. Takahashi, S. Todo and T. Moriuchi, Somatic mutations of the APC gene in primary breast cancers. Am. J. Pathol. 156, 1997-2005 (2000).
26. K. Y. Ho, W. H. Kalle, T. H. Lo, W. Y. Lam and C. M. Tang, Reduced expression of APC and DCC gene protein in breast cancer. Histopathology 35, 249-256 (1999).
27. Z. Jin, G. Tamura, T. Tsuchiya, K. Sakata, M. Kashiwaba, M. Osakabe and T. Motoyama. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br. J. Cancer 85, 69-73 (2001).
28. A. K. Virmani, A. Rathi, U. G. Sathyanarayana, A. Padar, C. X. Huang, H. T. Cunnigham, A. J. Farinas, S. Milchgrub, D. M. Euhus and A. F. Gazdar, Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res. 7, 1998-2004 (2001).
29. S. B. Rasmussen, L. J. T. Young and G. H. Smith, Preparing mammary gland whole mounts from mice. In Methods in Mammary Gland Biology and Breast Cancer Research (B. B. Asch, Ed.), pp 75-85. Kluwer Academic/Plenum Publishers, New York, 2000.
30. C. Luongo, A. R. Moser, S. Gledhill and W. F. Dove, Loss of Apc' in intestinal adenomas from Min mice. Cancer Res. 54, 5947-5952 (1994).
31. D. B. Levy, K. J. Smith, Y. Beazer-Barclay, S. R. Hamilton, B. Vogelstein and K. W. Kinzler, Inactivation of both APC alleles in human and mouse tumors. Cancer Res. 54, 5953-5958 (1994).
32. N. S. Fearnhead, M. P. Britton and W. F. Bodmer, The ABC of APC. Hum. Mol. Genet. 10, 721-733 (2001).
33. R. C. Gallagher, T. Hay, V. Meniel, C. Naughton, T. J. Anderson, H. Shibata, M. Ito, H. Clevers, T. Noda and A. R. Clarke, Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency. Oncogene 21, 6446-6457 (2002).
34. N. J. Kenney, G. H. Smith, E. Lawrence, J. C. Barrett and D. S. Salomon, Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland. J. Biomed. Biotechnol. 1, 133-143 (2001).
35. G. H. Smith, Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Rex. Treat. 39, 21-31 (1996).
36. Y. Shimada, J. Yasukawa-Barnes, R. Y. Kim, M. N. Could and K. H. Clifton, Age and radiation sensitivity of rat mammary clonogenic cells. Radiat. Res. 137, 118-123 (1994).
37. S. B. Tepera, P. D. McCrea and J. M. Rosen, A β-catenin survival signal is required for normal lobular development in the mammary gland. J. Cell Sci. 116, 1137-1149 (2003).
38. S. Hatsell, T. Rowlands, M. Hiremath and P. Cowin, β-Catenin and Tcfs in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 8, 145-158 (2003).
39. G. H. Smith and C. A. Boulanger, Mammary epithelial stem cells: Transplantation and self-renewal analysis. Cell Prolif. 36 (Suppl. 1), 3-15 (2003).
40. D. Trichopoulos, P. Lagiou and H. O. Adami. Towards an integrated model for breast cancer etiology: The crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res. 7, 13-17 (2005).
41. S. Nandi, R. C. Guzman and J. Yang, Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. USA 92, 3650-3657 (1995).
42. M. F. Rajewsky, J. Engelbergs, J. Thomale and T. Schweer, DNA repair: Counteragent in mutagenesis and carcinogenesis-accomplice in cancer therapy resistance. Mutat. Res. 462, 101-105 (2000).
43. J. Roose, G. Huls, M. van Beest, P. Moerer, K. van der Horn, R. Goldschmeding, T. Logtenberg and H. Clevers, Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1. Science 285, 1923-1926 (1999).
44. A. Imbert, R. Eelkema, S. Jordan, H. Feiner and P. Cowin, ΔN89β-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J. Cell Biol. 153, 555-568 (2001).
45. J. S. Michaelson and P. Leder, β-Catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 20, 5093-5099 (2001).
46. B. Y. Liu, S. P. McDermott, S. S. Khwaja and C. M. Alexander, The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. USA 101, 4158-4163 (2004).
47. Y. Li, B. Welm, K. Podsypanina, S. Huang, M. Chamorro, X. Zhang, T. Rowlands, M. Egeblad, P. Cowin and H. E. Varmus, Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. USA 100, 15853-15858 (2003).
48. R. H. Krech, K. Brunnert and H. Neumann, Primary squamous cell carcinoma of female mammary gland. Pathologe 19, 373-378 (1998).
49. H. Singh, S. P. Williams, V. Kinsella and G. R. Lynch, Postradiation squamous cell cancer of the breast. Cancer Invest. 18, 343-346 (2000).
50. R. S. Saad, J. F. Silverman, T. Julian, K. M. Clary and C. D. Sturgis, Atypical squamous metaplasia of seromas in breast needle aspirates from irradiated lumpectomy sites: A potential pitfall for false-positive diagnoses of carcinoma. Diagn. Cytopathol. 26, 104-108 (2002).